Journal of Clinical Endocrinology & Metabolism, Vol 65, 906-913, Copyright © 1987 by Endocrine Society

ARTICLES

The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome

PC Avgerinos, GP Chrousos, LK Nieman, EH Oldfield, DL Loriaux and GB Cutler Jr
Developmental Endocrinology, National Institutes of Health, Bethesda, Maryland 20892.

After surgical cure of Cushing's syndrome most patients develop transient secondary adrenal insufficiency that lasts for approximately 1 yr. Since ACTH-secreting pituitary adenomas generally respond to ovine CRH (oCRH), we tested the hypothesis that an early postoperative response to oCRH may indicate the presence of residual pituitary tumor and, therefore, predict recurrence. We also assessed the usefulness of oCRH for monitoring the recovery of the hypothalamic-pituitary-adrenal axis and for clarifying the pathophysiology of this condition. Thirty- four patients cured of Cushing's syndrome (29 with Cushing's disease, 3 with adrenal adenomas, and 2 with the ectopic ACTH syndrome) had an evening oCRH test 1-2 weeks after surgery. Nine patients (6 with Cushing's disease, 2 with adrenal adenomas, and 1 with the ectopic ACTH syndrome) participated in a longitudinal evaluation and had repeated oCRH and 1-h ACTH tests at 2-month intervals for a year after surgery. Patients were considered to be cured on the basis of at least 3 subnormal urinary [less than 20 micrograms/24 h (less than 55 nmol/day)] or morning plasma cortisol levels [0600-0900 h; less than 6 micrograms/dL (less than 170 nmol/L)] in the first 2 weeks after surgery. The plasma ACTH and cortisol responses to oCRH in the early postoperative period were subnormal in 23 and normal in 6 patients with Cushing's disease. Three patients developed recurrent Cushing's disease (3, 3, and 23 months after transphenoidal surgery). All 3 were among the 6 who had a normal early postoperative response to oCRH. All of the 23 patients who had a subnormal response to oCRH in the early postoperative period have remained in remission for an average follow- up period of 14 months (6-42 months). Thus, the recurrence rate was significantly greater in patients with normal oCRH tests in the early postoperative period (P less than 0.001, by chi 2 analysis). Surgically cured patients with adrenal adenomas or ectopic ACTH secretion also had subnormal plasma ACTH and cortisol responses to oCRH during the early postoperative period. During longitudinal evaluation for 12 months after surgery, the ACTH and cortisol responses to oCRH increased progressively (regardless of the cause of Cushing's syndrome). Cortisol responses to oCRH correlated significantly with the cortisol responses to exogenous ACTH (r = 0.89; P less than 0.00001). We conclude that most patients with Cushing's syndrome have suppressed responses to oCRH during the early postoperative period.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				G. Arnaldi, A. Angeli, A. B. Atkinson, X. Bertagna, F. Cavagnini, G. P. Chrousos, G. A. Fava, J. W. Findling, R. C. Gaillard, A. B. Grossman, et al. Diagnosis and Complications of Cushing's Syndrome: A Consensus Statement J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5593 - 5602. [Abstract] [Full Text] [PDF]

				G. MASTORAKOS and I. ILIAS Maternal and Fetal Hypothalamic-Pituitary-Adrenal Axes During Pregnancy and Postpartum Ann. N.Y. Acad. Sci., November 1, 2003; 997(1): 136 - 149. [Abstract] [Full Text] [PDF]

				A. J. Cleare The Neuroendocrinology of Chronic Fatigue Syndrome Endocr. Rev., April 1, 2003; 24(2): 236 - 252. [Abstract] [Full Text] [PDF]

				J. Newell-Price, D. G. Morris, W. M. Drake, M. Korbonits, J. P. Monson, G. M. Besser, and A. B. Grossman Optimal Response Criteria for the Human CRH Test in the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1640 - 1645. [Abstract] [Full Text] [PDF]

				A. J. Cleare, J. Miell, E. Heap, S. Sookdeo, L. Young, G. S. Malhi, and V. O'Keane Hypothalamo-Pituitary-Adrenal Axis Dysfunction in Chronic Fatigue Syndrome, and the Effects of Low-Dose Hydrocortisone Therapy J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3545 - 3554. [Abstract] [Full Text] [PDF]

				G. MASTORAKOS and I. ILIAS Maternal Hypothalamic-Pituitary-Adrenal Axis in Pregnancy and the Postpartum Period: Postpartum-Related Disorders Ann. N.Y. Acad. Sci., April 1, 2000; 900(1): 95 - 106. [Abstract] [Full Text] [PDF]

				C. Invitti, F. P. Giraldi, M. De Martin, and F. Cavagnini Diagnosis and Management of Cushing's Syndrome: Results of an Italian Multicentre Study J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 440 - 448. [Abstract] [Full Text]

				M. A. DEMITRACK and L. J. CROFFORD Evidence for and Pathophysiologic Implications of Hypothalamic-Pituitary-Adrenal Axis Dysregulation in Fibromyalgia and Chronic Fatigue Syndrome Ann. N.Y. Acad. Sci., May 1, 1998; 840(1): 684 - 697. [Abstract] [Full Text] [PDF]

				D. J. Devoe, W. L. Miller, F. A. Conte, S. L. Kaplan, M. M. Grumbach, S. M. Rosenthal, C. B. Wilson, and S. E. Gitelman Long-Term Outcome in Children and Adolescents after Transsphenoidal Surgery for Cushing's Disease J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3196 - 3202. [Abstract] [Full Text] [PDF]

				D. Michelson, E. Galliven, L. Hill, M. Demitrack, G. Chrousos, and P. Gold Chronic Imipramine Is Associated with Diminished Hypothalamic-Pituitary-Adrenal Axis Responsivity in Healthy Humans J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2601 - 2606. [Abstract] [Full Text] [PDF]

				G. Cizza, A. J. Lotsikas, J. Licinio, P. W. Gold, and G. P. Chrousos Plasma Leptin Levels Do not Change in Patients with Cushing's Disease Shortly after Correction of Hypercortisolism J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2747 - 2750. [Abstract] [Full Text] [PDF]

				L. D. Dorn, E. S. Burgess, T. C. Friedman, B. Dubbert, P. W. Gold, and G. P. Chrousos The Longitudinal Course of Psychopathology in Cushing's Syndrome after Correction of Hypercortisolism J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 912 - 919. [Abstract] [Full Text] [PDF]